Catalyst Wire Dossier Catalyst Wire Dossier

afatinib dimaleate

afatinib · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for afatinib dimaleate, covering 2025-11-18 to 2025-11-18. Get the full timeline:

Most recent: Clinical Trial Update: Exploratory Study of Inhaled Afatinib Dimaleate PK Profile [Phase 1]

See pricing